MRC1 and colorectal carcinoma: We also observed increase in MHCII molecule HLA-DR, a favorable prognostic marker in CRC [40,53], when CRC cells were exposed to increasing concentrations of NUC-3373, which was more pronounced in HCT116 cells, which may be due to MMR status.